The Diverse Potential of Gluten from Different Durum Wheat Varieties in Triggering Celiac Disease: A Multilevel In Vitro, Ex Vivo and In Vivo Approach
- PMID: 33233787
- PMCID: PMC7699868
- DOI: 10.3390/nu12113566
The Diverse Potential of Gluten from Different Durum Wheat Varieties in Triggering Celiac Disease: A Multilevel In Vitro, Ex Vivo and In Vivo Approach
Abstract
The reasons behind the increasing prevalence of celiac disease (CD) worldwide are still not fully understood. This study adopted a multilevel approach (in vitro, ex vivo, in vivo) to assess the potential of gluten from different wheat varieties in triggering CD. Peptides triggering CD were identified and quantified in mixtures generated from simulated gastrointestinal digestion of wheat varieties (n = 82). Multivariate statistics enabled the discrimination of varieties generating low impact on CD (e.g., Saragolla) and high impact (e.g., Cappelli). Enrolled subjects (n = 46) were: 19 healthy subjects included in the control group; 27 celiac patients enrolled for the in vivo phase. Celiacs were divided into a gluten-free diet group (CD-GFD), and a GFD with Saragolla-based pasta group (CD-Sar). The diet was followed for 3 months. Data were compared between CD-Sar and CD-GFD before and after the experimental diet, demonstrating a limited ability of Saragolla to trigger immunity, although not comparable to a GFD. Ex vivo studies showed that Saragolla and Cappelli activated immune responses, although with great variability among patients. The diverse potential of durum wheat varieties in triggering CD immune response was demonstrated. Saragolla is not indicated for celiacs, yet it has a limited potential to trigger adverse immune response.
Keywords: ELISA; celiac disease; durum wheat; gluten peptides; immune response.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Evaluation of the safety of ancient strains of wheat in coeliac disease reveals heterogeneous small intestinal T cell responses suggestive of coeliac toxicity.Clin Nutr. 2013 Dec;32(6):1043-9. doi: 10.1016/j.clnu.2013.02.003. Epub 2013 Feb 14. Clin Nutr. 2013. PMID: 23465776
-
A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial.Nutrients. 2019 Mar 27;11(4):712. doi: 10.3390/nu11040712. Nutrients. 2019. PMID: 30934747 Free PMC article. Clinical Trial.
-
Prevalence of Wheat/Gluten-Related Disorders and Gluten-Free Diet in Paraguay: An Online Survey-Based Study.Nutrients. 2021 Jan 27;13(2):396. doi: 10.3390/nu13020396. Nutrients. 2021. PMID: 33513886 Free PMC article.
-
Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients.Nutrients. 2013 Oct 21;5(10):4174-83. doi: 10.3390/nu5104174. Nutrients. 2013. PMID: 24152750 Free PMC article. Review.
-
Treatment of celiac disease: from gluten-free diet to novel therapies.Minerva Pediatr. 2014 Oct;66(5):501-16. Minerva Pediatr. 2014. PMID: 24938882 Review.
References
-
- Mustalahti K., Catassi C., Reunanen A., Fabiani E., Heier M., McMillan S., Murray L., Metzger M.-H., Gasparin M., Bravi E., et al. The prevalence of celiac disease in Europe: Results of a centralized, international mass screening project. Ann. Med. 2010;42:587–595. doi: 10.3109/07853890.2010.505931. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous